PF-06741086
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for PF-06741086, covering 2016-08-12 to 2026-08-14. Get the full timeline:
Most recent: Clinical Trial Results: Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B [Phase 3]